{
    "code": "02024617",
    "time": "2015-06-25 18:12:27",
    "許可證字號": "衛署藥輸字第024617號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/02\/08",
    "發證日期": "96\/02\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202461701",
    "中文品名": "依瑞諾丁濃縮注射液",
    "英文品名": "Irinotecan Injection Concentrate",
    "適應症": "晚期性大腸直腸癌之第一線治療藥物，與5-FU及folinic acid合併、使用於未曾接受過化學治療之患者、單獨使用於曾接受5-FU療程治療無效之患者。",
    "劑型": "270注射劑",
    "包裝": "2毫升、5毫升小瓶 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "IRINOTECAN HYDROCHLORIDE TRIHYDRATE",
    "限制項目": [
        "02輸入",
        "25監視中學名藥"
    ],
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "申請商地址": "台北市大安區敦化南路2段333號18樓",
    "主製造廠": {
        "製造廠名稱": "F020031100  HOSPIRA AUSTRALIA PTY LTD.",
        "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037710",
            "成分名稱": "IRINOTECAN HYDROCHLORIDE TRIHYDRATE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 P02461702依瑞諾丁Irinotecan36x26.2cm-背面final -103-01-07.pdf P02461702依瑞諾丁Irinotecan36x26.2cm-正面final-103-01-07.pdf 020246170008.jpg 020246170007.jpg 020246170006.jpg 020246170005.jpg 020246170004.jpg 020246170003.jpg 020246170002.jpg 020246170001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02024617&Seq=010&Type=9"
        },
        {
            "title": "外盒 020246170008.jpg 020246170007.jpg 020246170006.jpg 020246170005.jpg 020246170004.jpg 020246170003.jpg 020246170002.jpg 020246170001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02024617&Seq=008&Type=8"
        }
    ]
}